| Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect WH Sommer, J Lidström, H Sun, D Passer, R Eskay, SCJ Parker, SH Witt, ... Human mutation 31 (8), E1594-E1608, 2010 | 118 | 2010 |
| PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized … C Celum, S Hosek, M Tsholwana, S Kassim, S Mukaka, BJ Dye, S Pathak, ... PLoS medicine 18 (6), e1003670, 2021 | 97 | 2021 |
| Characterization of human immunodeficiency virus (HIV) infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV … MA Marzinke, B Grinsztejn, JM Fogel, E Piwowar-Manning, M Li, L Weng, ... The Journal of Infectious Diseases 224 (9), 1581-1592, 2021 | 77 | 2021 |
| Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial J AIDS 74 (1), 112-116, 2017 | 77* | 2017 |
| Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052) JM Fogel, L Wang, TL Parsons, SS Ou, E Piwowar-Manning, Y Chen, ... The Journal of infectious diseases 208 (10), 1624-1628, 2013 | 76 | 2013 |
| Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to … JD Church, SB Omer, LA Guay, W Huang, J Lidstrom, P Musoke, F Mmiro, ... The Journal of infectious diseases 198 (7), 1075-1082, 2008 | 69 | 2008 |
| Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants J Fogel, Q Li, TE Taha, DR Hoover, NI Kumwenda, LM Mofenson, ... Clinical infectious diseases 52 (8), 1069-1076, 2011 | 57 | 2011 |
| Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection MA Marzinke, W Clarke, L Wang, V Cummings, TY Liu, ... Clinical infectious diseases 58 (1), 117-120, 2014 | 56 | 2014 |
| Characterization of human immunodeficiency virus (HIV) infections in women who received injectable cabotegravir or tenofovir disoproxil fumarate/emtricitabine for HIV … SH Eshleman, JM Fogel, E Piwowar-Manning, G Chau, V Cummings, ... The Journal of infectious diseases 225 (10), 1741-1749, 2022 | 45 | 2022 |
| Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence J Kakko, J von Wachenfeldt, KD Svanborg, J Lidström, CS Barr, M Heilig Biological Psychiatry 63 (2), 172-177, 2008 | 40 | 2008 |
| Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants JM Fogel, A Mwatha, P Richardson, ER Brown, T Chipato, M Alexandre, ... The Pediatric infectious disease journal 32 (4), e164-e169, 2013 | 34 | 2013 |
| Virologic outcomes in early antiretroviral treatment: HPTN 052 SH Eshleman, EA Wilson, XC Zhang, SS Ou, E Piwowar-Manning, ... HIV clinical trials 18 (3), 100-109, 2017 | 31 | 2017 |
| Brief report: impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays JM Fogel, E Piwowar-Manning, B Debevec, T Walsky, K Schlusser, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (4), 426-430, 2017 | 27 | 2017 |
| Brief report: HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV prevention trials network 052 trial JM Fogel, SE Hudelson, SS Ou, S Hart, C Wallis, MG Morgado, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (3), 304-309, 2016 | 26 | 2016 |
| Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening E Piwowar-Manning, JM Fogel, O Laeyendecker, S Wolf, V Cummings, ... HIV clinical trials 15 (2), 62-68, 2014 | 26 | 2014 |
| Association of HIV diversity and survival in HIV-infected Ugandan infants MM James, L Wang, P Musoke, D Donnell, J Fogel, WI Towler, L Khaki, ... PLoS One 6 (4), e18642, 2011 | 25 | 2011 |
| Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061 I Chen, MB Connor, W Clarke, MA Marzinke, V Cummings, A Breaud, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (4), 446-452, 2015 | 24 | 2015 |
| Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083 MA Marzinke, B Grinsztejn, JM Fogel, E Piwowar-Manning, M Li, L Weng, ... J Infect Dis 224 (9), 1581-1592, 2021 | 23 | 2021 |
| Seroepidemiology of human papillomavirus 16 (HPV16) L2 and generation of L2-specific human chimeric monoclonal antibodies JW Wang, S Jagu, WH Wu, RP Viscidi, A Macgregor-Das, JM Fogel, ... Clinical and Vaccine Immunology 22 (7), 806-816, 2015 | 22 | 2015 |
| Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis J Fogel, DR Hoover, J Sun, LM Mofenson, MG Fowler, AW Taylor, ... AIDS 25 (7), 911-917, 2011 | 22 | 2011 |
